Countries North America
Wasatch BioLabs and Oxford Nanopore Collaborate on Breakthrough Direct Whole Methylome Sequencing Product
Wasatch Biolabs (WBL), a disruptive R&D and high-throughput clinical laboratory, today announced a collaboration with Oxford Nanopore Technologies (ONT...
November 04, 2024 | News
Thermo Fisher’s $22M OSD Investment: Shervin Hebbi on Accelerating Drug Development with Cutting-Edge Technology
In an exclusive Q&A with BioPharma APAC, Shervin Hebbi, Vice President of Oral Solid Dose (OSD) – North America at Thermo Fisher ...
November 01, 2024 | Interview
Jubilant Radiopharma Partners with Simplified Imaging Solutions to Launch First Comprehensive Nuclear Medicine Solution in the U.S.
Jubilant Radiopharma, a business segment of Jubilant Pharmova Limited, with the second largest network of Radiopharmacies in the United States (U.S.) and S...
October 31, 2024 | News
Siemens Healthineers Expands Atellica Integrated Automation to Atellica CI Analyzer, Transforming Clinical Lab Operations
Siemens Healthineers is pleased to announce the expansion of its Atellica Integrated Automation solution to the Atellica CI Analyzer, bringing advanced aut...
October 31, 2024 | Product Spotlight
Australia's Telix Pharmaceuticals Partners with Subtle Medical for AI-Powered PET Imaging, Enhancing Illuccix® Efficiency and Patient Experience
Telix Pharmaceuticals announces a partnership with California-based Subtle Medical, Inc. (Subtle Medical) for artificial intelligence (AI)-powere...
October 31, 2024 | News
Complete Genomics Integrates DNBSEQ Platforms with NVIDIA Parabricks to Enhance Speed, Accuracy, and Affordability of Genomic Analysis
Complete Genomics announced an integration of its next-generation sequencing (NGS) DNBSEQ platforms* with NVIDIA Parabricks software for secondary analysis...
October 30, 2024 | News
I Peace, Inc. Introduces HLA-Homozygous iPSC Line to Boost Compatibility and Accessibility in Allogenic Cell Therapies
I Peace, Inc., a leading GMP cell contract development and manufacturing organization (CDMO) specializing in induced pluripotent stem cells (iPSCs) and iPS...
October 30, 2024 | News
Merck Invests €70 Million to Triple ADC Manufacturing Capacity at St. Louis Facility, Bolstering Bioconjugation Excellence
Merck, a leading science and technology company, announced a € 70 million expansion of its ADC manufacturing capabilities and capacity at its Bioconju...
October 30, 2024 | News
Innovent's Picankibart Shows Promising Results in Phase 2 Trial for Psoriasis Patients Unresponsive to Previous Biologics
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality me...
October 29, 2024 | News
LakeShore Biopharma Gains NMPA Approval for Phase III Trial of Simplified Four-Dose Rabies Vaccine Regimen
LakeShore Biopharma Co., Ltd (Nasdaq: LSB) ("LakeShore Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developin...
October 28, 2024 | News
Corvia Medical’s Atrial Shunt Demonstrates Long-Term Efficacy in Heart Failure Patients: Three-Year Trial Results Published
Corvia Medical, Inc, a company dedicated to transforming the treatment of heart failure, announced impressive three-year results from its REDUCE LAP-HF II ...
October 28, 2024 | News
EpiVax and CUBRC Secure $2M FDA Contract to Develop T Cell Assay Standards for Generic Drug Immunogenicity
EpiVax, Inc. ("EpiVax") and CUBRC, Inc. ("CUBRC") announce that they have been awarded a two-year, $2 million contract (#75F40124C00094) from the...
October 25, 2024 | News
Medera Advances HFpEF Gene Therapy to High-Dose Cohort After Promising Results
Heart failure is a global pandemic with an estimated 64.3 million cases worldwide, costing over US$100B per year Heart failure with preserved ...
October 25, 2024 | News
Australia's Telix Pharmaceuticals Secures FDA Priority Review for Pixclara® (TLX101-CDx) Glioma Imaging Agent
Telix Pharmaceuticals announces that the United States (U.S.) Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) for ...
October 24, 2024 | News
Most Read
- The New AI Gold Rush: Western Pharma’s Billion-Dollar Bet on Chinese Biotech
- Top 25 Biotech & Biopharma Leaders in Sustainable Innovation, 2025
- China’s Biopharma Dealmaking Surges in H1 2025, Driven by Record Licensing and Oncology Focus
- Chikungunya in China: How a “Forgotten” Arbovirus Found the Perfect Storm
- How Innovation Gaps in Biopharma Raise New Safety Concerns
- Smart Implants and the Future of Musculoskeletal Injury Treatment
- How Ethical Gaps in Psychiatry Could Undermine Biopharma Progress
- The Evolving Landscape of Women’s Health Innovation in the Asia-Pacific
- Using NLP-Driven Decision Support in Emergency Health Assistance
- Taiwan Steps Into the Global Spotlight With a New Cancer Therapy
- The Role of Unique Device Identification (UDI) in Tracing Medical Device Safety
- The Importance of a Patient’s Mental Health During Clinical Trials
Bio Jobs
- The State of Biotech and Life Science Jobs in Asia Pacific – 2025
- Avantor’s New CEO Ligner Aims to Unlock Global Potential and Deliver Shareholder Value
- AstraZeneca Commits $50 Billion to U.S. Expansion by 2030 in Biggest-Ever Global Investment
- Thermo Fisher, SAMRC, and South Africa’s Department of Science and Innovation Launch CATIR to Nurture Next-Gen Scientists
- Cube Biotech Appoints Former Sartorius CEO Dr. Joachim Kreuzburg to Board of Directors
- FDA’s AI Transition Marks a Turning Point in Drug Review: Industry Faces Pressure to Adapt Amid 20% Workforce Cut
- WuXi XDC Completes Mechanical Build of Singapore Bioconjugate Manufacturing Hub
News
Editor Picks
